Registration

SL STRATEGIES, LLC for BAVARIAN NORDIC

Firm
Client
Income
—
Expenses
—

What was lobbied

4 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Project BioShield; biodefense; Biomedical Advanced Reserach and Development Authority funding; vaccine research, development, manufacturing; infectious diseases; cancer; Labor-HHS Appropriations bills

LobbyistCovered position, as disclosed
SARA LOVE RAWLINGS New Senate Committee on Appropriations

Medical/Disease Research/Clinical Labs MED

Project BioShield; biodefense; Biomedical Advanced Reserach and Development Authority funding; vaccine research, development, manufacturing; infectious diseases; cancer; Labor-HHS Appropriations bills

LobbyistCovered position, as disclosed
SARA LOVE RAWLINGS New Senate Committee on Appropriations

Disaster Planning/Emergencies DIS

Project BioShield; biodefense; Biomedical Advanced Reserach and Development Authority funding; vaccine research, development, manufacturing; infectious diseases; cancer; Labor-HHS Appropriations bills

LobbyistCovered position, as disclosed
SARA LOVE RAWLINGS New Senate Committee on Appropriations

Budget/Appropriations BUD

Project BioShield; biodefense; Biomedical Advanced Reserach and Development Authority funding; vaccine research, development, manufacturing; infectious diseases; cancer; Labor-HHS Appropriations bills

LobbyistCovered position, as disclosed
SARA LOVE RAWLINGS New Senate Committee on Appropriations

Foreign entities

Foreign owners and affiliates the filer disclosed. Amounts are as declared on this filing.

EntityCountryPrincipal place of businessOwnershipContribution declared
BAVARIAN NORDIC A/S Denmark Denmark 100.0% —

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.